Emma Walmsley has served as CEO of GlaxoSmithKline since 2017. From the Philadelphia Business Journal. GSK is making a change at the top. The London-based Big Pharma company, which has major ...
Luke Miels had only been at the helm of GSK for 20 days before he signed off on his first multibillion-dollar buyout, and the CEO is clear on what else will attract his interest. | Luke Miels had only ...
Miels succeeded Emma Walmsley to become GSK’s new CEO at the beginning of 2026, inheriting the role as GSK posted what he ...
(Alliance News) - Outgoing GSK PLC Chief Executive Officer Emma Walmsley has said the US is the best place to invest, in the latest blow to Britain's pharmaceutical sector, after a raft of drugs firms ...
SALES FORECAST: The U.K. drugmaker is expected to post fourth-quarter sales of 8.495 billion pounds ($11.61 billion), according to consensus estimates provided by the company. GSK posted 8.12 billion ...
British pharmaceutical group GSK reported Wednesday a sharp rise in annual net profit, boosted by strong sales of HIV, respiratory and cancer treatments as it recovered from costly US lawsuits ...
Outgoing GSK boss Dame Emma Walmsley has said the US is the best place to invest, in the latest blow to Britain’s pharmaceutical sector, after a raft of drugs firms have scrapped or paused plans to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results